MAR-DILTIAZEM T 360 MG — DIN 02465418
DILTIAZEM HYDROCHLORIDE : 360 MG · MARCAN PHARMACEUTICALS INC · CAPSULE (EXTENDED RELEASE) · wholesale supply in Canada
Health Canada status: MARKETED
What is MAR-DILTIAZEM T?
MAR-DILTIAZEM T 360 MG contains DILTIAZEM HYDROCHLORIDE : 360 MG. It is listed in the Health Canada Drug Product Database under DIN 02465418, held by MARCAN PHARMACEUTICALS INC, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 22-May-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MAR-DILTIAZEM T used for?
Mar-Diltiazem T (Diltiazem Hydrochloride Extended-Release Capsules) is indicated for: Essential Hypertension. Mar-Diltiazem T is indicated for the treatment of mild to moderate essential hypertension. Chronic Stable Angina. Mar-Diltiazem T is indicated for the management of chronic stable angina (effort-associated angina) without evidence of vasospasm in patients who remain symptomatic despite adequate doses of beta-blockers and/or organic nitrates or who cannot tolerate these agents.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Diltiazem cost around the world?
Diltiazem is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Italy publishes a prezzo al pubblico (classe A). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 21 | 135 | USD███.██ |
| Morocco | PPV (public price) | 12 | 27 | MAD███.██ |
| Italy | prezzo al pubblico (classe A) | 21 | 24 | EUR███.██ |
| Australia | ex-manufacturer | 5 | 20 | AUD███.██ |
| Greece | producer price (ex-factory) | 10 | 10 | EUR███.██ |
| Romania | max producer price | 5 | 6 | RON███.██ |
| South Africa | single exit price | 2 | 3 | ZAR███.██ |
| Slovakia | categorised final price | 2 | 2 | EUR███.██ |
| United Kingdom | hospital | 1 | 1 | GBP███.██ |
228 pack listings across 79 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Diltiazem pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Diltiazem in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
31 holders have a Canadian DIN containing Diltiazem, across 175 DINs, of which 75 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 20 | 13 | ACT DILTIAZEM CD, DILTIAZEM HYDROCHLORIDE INJECTION, TEVA-DILTIAZEM, TEVA-DILTIAZEM CD, TEVA-DILTIAZEM T, +1 more | Sourceable in Canada |
| BAUSCH HEALTH, CANADA INC. | 19 | 10 | CARDIZEM CD, TEVA-DILTIAZEM HCL ER, TIAZAC, TIAZAC XC | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 9 | 9 | JAMP DILTIAZEM CD, JAMP DILTIAZEM T | Sourceable in Canada |
| MANTRA PHARMA INC | 9 | 9 | M-DILTIAZEM CD, M-DILTIAZEM T | Sourceable in Canada |
| SANIS HEALTH INC | 9 | 9 | DILTIAZEM CD, DILTIAZEM T | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC | 8 | 8 | MAR-DILTIAZEM CD, MAR-DILTIAZEM T | Sourceable in Canada |
| PRO DOC LIMITEE | 15 | 4 | DILTIAZEM TZ, DILTIAZEM-30 TAB 30MG, DILTIAZEM-60 TAB 60MG, DILTIAZEM-CD, PRO-DILTIAZEM CD | Sourceable in Canada |
| APOTEX INC | 13 | 4 | APO-DILTIAZ CD, APO-DILTIAZ INJECTABLE, APO-DILTIAZ SR, APO-DILTIAZ TZ | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 4 | 4 | DILTIAZEM CD | Sourceable in Canada |
| AA PHARMA INC | 2 | 2 | AA-DILTIAZ | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 10 | 1 | DILTIAZEM HYDROCHLORIDE INJECTION, SANDOZ DILTIAZEM CD, SANDOZ DILTIAZEM T | Sourceable in Canada |
| MARCAN PHARMACEUTICALS INC 2 Gurdwara Rd., Suite 400 Ottawa Ontario Canada K2E 1A2 | 1 | 1 | MAR-DILTIAZEM T | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 360 MG |
|---|---|
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route | ORAL |
| Pack configuration (monograph) | 120 mg capsules are supplied in bottles of 100. 180 mg capsules are supplied in bottles of 100. 240 mg capsules are supplied in bottles of 100. 300 mg capsules are supplied in bottles of 100. 360 mg capsules are supplied in bottles of 100. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Diltiazem |
|---|---|
| ATC code | C08DB01 |
| AHFS class | 24:28.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02465418 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2465418 |
| Brand name | MAR-DILTIAZEM T |
| Generic / active ingredient | DILTIAZEM HYDROCHLORIDE : 360 MG |
| Market authorization holder | MARCAN PHARMACEUTICALS INC |
| Health Canada schedule | Prescription |
| ATC code | C08DB01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C08DB |
| Current status | MARKETED |
| Status date | 22-May-2018 |
| Original market date | 2018-05-22 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Hypertension: 180-240 mg once daily (max 360 mg). Angina: 120-180 mg once daily (max 360 mg). Do not chew or crush. Titrate over 7-14 days.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Sick sinus syndrome, 2nd/3rd-degree AV block, hypersensitivity, severe hypotension (<90 mmHg), severe bradycardia (<40 bpm), LV failure with pulmonary congestion, pregnancy, breastfeeding.
Warnings and precautions
May cause abnormally slow heart rates or AV block. Use caution in CHF, reduced LV function, or hypotension. Risk of acute renal failure, hepatic injury, and new onset diabetes.
Is Diltiazem in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
75 of 175 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-DILTIAZ | 30 MG | TABLET | AA PHARMA INC | MARKETED | 00771376 |
| AA-DILTIAZ | 60 MG | TABLET | AA PHARMA INC | MARKETED | 00771384 |
| APO-DILTIAZ CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230997 |
| APO-DILTIAZ CD | 240 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230999 |
| APO-DILTIAZ CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02230998 |
| APO-DILTIAZ CD | 300 MG | CAPSULE (CONTROLLED-DELIVERY) | APOTEX INC | MARKETED | 02229526 |
| DILTIAZEM CD | 180 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400448 |
| DILTIAZEM CD | 120 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400421 |
| DILTIAZEM CD | 240 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400456 |
| DILTIAZEM CD | 300 MG | CAPSULE (CONTROLLED-DELIVERY) | SANIS HEALTH INC | MARKETED | 02400464 |
2 · Same class — other molecules in ATC C08DB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diltiazem | AA-DILTIAZ · ACT DILTIAZEM CD · ALTI-DILTIAZEM TAB 30MG · ALTI-DILTIAZEM TAB 60MG · +61 more | 175 | 75 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C08D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C08DA | Verapamil | 53 | 5 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is MAR-DILTIAZEM T called?
The same molecule, Diltiazem, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Diltiazem Sandoz CD | Latin | Australia |
| Vasocardol CD | Latin | Australia |
| ADIZEM | Latin | Morocco |
| PROGOR | Latin | Morocco |
| BI-TILDIEM LP | Latin | Morocco |
| Cardizem CD | Latin | Australia |
| MONO-TILDIEM LP | Latin | Morocco |
| Cardizem | Latin | Australia |
| TILDIEM | Latin | Morocco |
| Vasocardol | Latin | Australia |
| ALTIAZEM | Latin | Morocco |
| CRONODINE LP | Latin | Morocco |
| Dilatam | Latin | South Africa |
| DILRENE LP | Latin | Morocco |
| RETALZEM | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.